Thanks to Apple, Alivecor goes more DTC. Part II: Software as a drug.

Issue 055.

Get E&O weekly. | Subscribe

Digital health research from Brian Dolan.

Welcome to E&O.

Last week I wrote up how Welldoc became the first company to get its digital therapy a billing code like a drug. Next week I am open to ideas -- what should E&O dig into? Here's what's happening this week:

Meant to include this last week: In Issue 053 I wrote about an RCT focused on a coach-led intervention for depression and anxiety. Small detail, but I missed a step in the IP licensing daisy-chain. Here's how it should have read: "A startup called Actualize Therapy has licensed the intervention for commercialization from the researchers, who incorporated as Adaptive Health." I originally thought Adaptive was the licensee and not the licensor.
Striiv, which at one point tried to compete with Fitbit in the early fitness wearable market, looks to be going under finally. Its founding CEO

Paying Subscribers Only

It's a good one, too.

This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Thanks to Apple, Alivecor goes more DTC. Part II: Software as a drug.

Welcome to E&O.

Paying Subscribers Only

Full access to E&O's research and newsletters.

New! E&O's free weekly newsletter.